Product Information
CHLOROQUINE PH 250 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $2.6837 per EA under NDC 00115279006. Its NADAC has been published 231 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115279006
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CHLOROQUINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA080880On Market Since
5/10/2022
Pharmacological Classes
Price Statistics
The NADAC for CHLOROQUINE PH 250 MG TABLET has been published 231 times since Nov 28, 2013, and over the history we have for it it has risen 209.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6837 per EA |
|---|---|
| All-time high | $2.8586 (Aug 13, 2025) |
| All-time low | $0.8668 (Nov 28, 2013) |
| 52-week high | $2.8586 |
| 52-week low | $2.2329 |
| Median price | $1.0930 |
| Average price | $1.6495 |
| Largest weekly change | +137.0% (May 22, 2024) |
| Weeks tracked | 231 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the CHLOROQUINE PHOSPHATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CHLOROQUINE PH 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLOROQUINE PH 250 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $2.6837 per EA (NDC 00115279006), effective Jun 24, 2026.
How has the price of CHLOROQUINE PH 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLOROQUINE PH 250 MG TABLET has risen 209.6%. It has been tracked across 231 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CHLOROQUINE PH 250 MG TABLET?
Since Nov 28, 2013, the NADAC for CHLOROQUINE PH 250 MG TABLET has ranged from a low of $0.8668 (Nov 28, 2013) to a high of $2.8586 (Aug 13, 2025), with a median of $1.0930 per EA.
Are there cheaper alternatives to CHLOROQUINE PH 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CHLOROQUINE PH 250 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CHLOROQUINE PH 250 MG TABLET?
CHLOROQUINE PH 250 MG TABLET (NDC 00115279006) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification